References
- Lacey DL, Boyle WJ, Simonet WS, Kostenuik PJ, Dougall WC, Sullivan JK, San Martin J, Dansey R. Bench to bedside: elucidation of the OPG-RANK-RANKL pathway and the development of denosumab. Nat. Rev. Drug Discov. 2012;11:401–419.10.1038/nrd3705
- Inada M, Matsumoto C, Uematsu S, Akira S, Miyaura C. Membrane-bound prostaglandin E synthase-1-mediated prostaglandin E2 production by osteoblast plays a critical role in lipopolysaccharide-induced bone loss associated with inflammation. J. Immunol. 2006;177:1879–1885.10.4049/jimmunol.177.3.1879
- Matsumoto C, Ashida N, Yokoyama S, Tominari T, Hirata M, Ogawa K, Sugiura M, Yano M, Inada M, Miyaura C. The protective effects of β-cryptoxanthin on inflammatory bone resorption in a mouse experimental model of periodontitis. Biosci. Biotechnol. Biochem. 2013;77:860–862.
- Okuyama S, Shimada N, Kaji M, Morita M, Miyoshi K, Minami S, Amakura Y, Yoshimura M, Yoshida T, Watanabe S, Nakajima M, Furukawa Y. Heptamethoxyflavone, a citrus flavonoid, enhances brain-derived neurotrophic factor production and neurogenesis in the hippocampus following cerebral global ischemia in mice. Neurosci. Lett. 2012;528:190–195.10.1016/j.neulet.2012.08.079
- Kou MC, Fu SH, Yen JH, Weng CY, Li S, Ho CT, Wu MJ. Effects of citrus flavonoids, 5-hydroxy-3,6,7,8,3′,4′-hexamethoxyflavone and 3,5,6,7,8,3′,4′-heptamethoxyflavone, on the activities of macrophage scavenger receptors and the hepatic LDL receptor. Food Funct. 2013;4:602–609.10.1039/c3fo30301b
- Miyaura C, Inada M, Matsumoto C, Ohshiba T, Uozumi N, Shimizu T, Ito A. An essential role of cytosolic phospholipase A2 alpha in prostaglandin E2-mediated bone resorption associated with inflammation. J. Exp. Med. 2003;197:1303–1310.10.1084/jem.20030015
- Asagiri M, Takayanagi H. The molecular understanding of osteoclast differentiation. Bone. 2007;40:251–264.10.1016/j.bone.2006.09.023
- Lerner UH, Gustafson GT. Inhibition of bone resorption in vitro by serine-esterase inhibitors. Biochim. Biophys. Acta. 1988;964:129–136.10.1016/0304-4165(88)90158-4
- Delaisse JM, Eeckhout Y, Sear C, Galloway A, McCullagh K, Vaes G. A new synthetic inhibitor of mammalian tissue collagenase inhibits bone resorption in culture. Biochem. Biophys. Res. Commun. 1985;133:483–490.10.1016/0006-291X(85)90932-5
- Ishimi Y. Soybean isoflavones in bone health. Forum Nutr. 2009;61:104–116.10.1159/000212743
- Hirata M, Matsumoto C, Takita M, Miyaura C, Inada M. Naringin suppresses osteoclast formation and enhances bone mass in mice. J. Health Sci. 2009;55:463–467.10.1248/jhs.55.463
- Harada S, Tominari T, Matsumoto C, Hirata M, Takita M, Inada M, Miyaura C. Nobiletin, a polymethoxy flavonoid, suppresses bone resorption by inhibiting NFκB-dependent prostaglandin E synthesis in osteoblasts and prevents bone loss due to estrogen deficiency. J. Pharmacol. Sci. 2011;115:89–93.10.1254/jphs.10193SC
- Tominari T, Hirata M, Matsumoto C, Inada M, Miyaura C. Polymethoxy flavonoids, nobiletin and tangeretin, prevent lipopolysaccharide-induced inflammatory bone loss in an experimental model for periodontitis. J. Pharmacol. Sci. 2012;119:390–394.10.1254/jphs.11188SC